(Updated - January 18, 2023 7:15 AM EST)

Canaccord Genuity analyst Whitney Ijem initiates coverage on Sigilon Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE